Keyword: Vetter

Chemistry & Life Sciences

The Evolution of the CDMO Industry

11.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine...

Chemistry & Life Sciences

Expert Statement: Thomas Otto and Peter Soelkner, Vetter

02.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Markets & Companies

Patient Centricity: The New Nexus for CDMOs

11.11.2019 - On the occasion of the pharma trade show CPhI Worldwide 2019, which took place in Frankfurt on November 5-7, CPhI has released its annual report, analyzing key trends and...

News

Vetter Appoints Oliver Albrecht as Managing Director

08.04.2015 - Vetter, a leading contract development and manufacturing organization headquartered at Ravensburg, Germany, announced the appointment of Oliver Albrecht as a new Managing Director...

News

Vetter Announces Personnel Changes in its Development Service Division

24.10.2014 - Dr. Susanne Resatz, formerly Manager Process Development and Manufacturing at Vetter's clinical development facility in Chicago, Illinois, has assumed the role of President. Resatz...

News

iBIO and iBIO Institute Boards Elect Andy Hull and Linda Friedman as 2014 Chairs

24.01.2014 - The Illinois Biotechnology Industry Organization (iBIO) today announced the election of Andy Hull as chairman of the iBIO Board of Directors, and the election of Linda Friedman, as...

News

Vetter's Newest Facility Successfully Completes FDA Inspection

28.03.2013 - Vetter, a contract development and manufacturing organization (CDMO), announced today that its new center for visual inspection and logistics passed its first GMP inspection by the...